Sigrid Hatse
- Oncology top 1%
- Molecular Biology top 5%
- Immunology top 2%
- Virology top 1%
- Infectious Diseases top 2%
- Co-authors
- Erik De ClercqDominique ScholsKatrien PrincenGary BridgerKurt VermeireJan BalzariniHans WildiersSandra Liekens
- Topics
- HIV Research and Treatment (23 papers)Chemokine receptors and signaling (17 papers)HIV/AIDS drug development and treatment (14 papers)
- Cited by
- VirologyOncologyImmunology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- BelgiumUnited StatesItaly
In The Last Decade
Sigrid Hatse
89 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 130
- Oncology 1.8k
- Molecular Biology 1.5k
- Immunology 1.1k
- Virology 711
- Infectious Diseases 631
Countries citing papers authored by Sigrid Hatse
This map shows the geographic impact of Sigrid Hatse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigrid Hatse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigrid Hatse more than expected).
Fields of papers citing papers by Sigrid Hatse
This network shows the impact of papers produced by Sigrid Hatse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigrid Hatse. The network helps show where Sigrid Hatse may publish in the future.
Co-authorship network of co-authors of Sigrid Hatse
This figure shows the co-authorship network connecting the top 25 collaborators of Sigrid Hatse. A scholar is included among the top collaborators of Sigrid Hatse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigrid Hatse. Sigrid Hatse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 44 | |
| 6 | 18 | |
| 7 | 8 | |
| 8 | Low 25-hydroxyvitamin d3 serum levels are associated with larger breast tumor size | 2 |
| 9 | Chemotherapy of human immunodeficiency virus by pradimicin A: a novel therapeutic concept for treatment of glycosylated enveloped viruses | 2 |
| 10 | 105 | |
| 11 | Virus resistance to the CXCR4 inhibitor AMD070 develops slowly and does not induce a co-receptor switch | 2 |
| 12 | In vitro anti-HIV activity profile of AMD887, a novel CCR5 antagonist, in combination with the CXCR4 inhibitor AMD070 | 5 |
| 13 | Anti-HIV activity profile of AMD070, an orally bioavailable CXCR4 antagonist | 4 |
| 14 | In vitro synergy between the CD4 down-modulating compound, CADA, and multiple anti-HIV drugs | 2 |
| 15 | 9 | |
| 16 | Mannose-specific plant lectins may qualify as efficient microbicides against human immunodeficiency virus transmission | 1 |
| 17 | 215 | |
| 18 | 23 | |
| 19 | 4 | |
| 20 | 11 |
About Sigrid Hatse
Sigrid Hatse is a scholar working on Virology, Geriatrics and Gerontology and Oncology, having authored 97 papers that have together received 4.1k indexed citations. Recurring topics across this work include HIV Research and Treatment (23 papers), Chemokine receptors and signaling (17 papers) and HIV/AIDS drug development and treatment (14 papers). The work is most often cited by research in Virology (711 citations), Oncology (1.8k citations) and Immunology (1.1k citations). Sigrid Hatse has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include Erik De Clercq, Dominique Schols, Katrien Princen, Gary Bridger, Kurt Vermeire, Jan Balzarini, Hans Wildiers, Sandra Liekens, Jan Balzarini and Thue W. Schwartz. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.